237 related articles for article (PubMed ID: 34351910)
1. The Δ40p53 isoform inhibits p53-dependent eRNA transcription and enables regulation by signal-specific transcription factors during p53 activation.
Levandowski CB; Jones T; Gruca M; Ramamoorthy S; Dowell RD; Taatjes DJ
PLoS Biol; 2021 Aug; 19(8):e3001364. PubMed ID: 34351910
[TBL] [Abstract][Full Text] [Related]
2. Δ40p53 is involved in the inactivation of autophagy and contributes to inhibition of cell death in HCT116-Δ40p53 cells.
Zang Y; Shi Y; Liu K; Qiao L; Guo X; Chen D
Oncotarget; 2017 Feb; 8(8):12754-12763. PubMed ID: 28061446
[TBL] [Abstract][Full Text] [Related]
3. The human ΔNp53 isoform triggers metabolic and gene expression changes that activate mTOR and alter mitochondrial function.
Lin SC; Karoly ED; Taatjes DJ
Aging Cell; 2013 Oct; 12(5):863-72. PubMed ID: 23734707
[TBL] [Abstract][Full Text] [Related]
4. Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53.
Hafsi H; Santos-Silva D; Courtois-Cox S; Hainaut P
BMC Cancer; 2013 Mar; 13():134. PubMed ID: 23514281
[TBL] [Abstract][Full Text] [Related]
5. [Effect of Δ40p53 isoform on enhancing the pro-apoptotic function of p53 in tumor cells].
Wang BS; Zhao HW; Qiao LX; Shan JQ; Hou QS; Chen DX; Guo HL
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):332-338. PubMed ID: 28535648
[No Abstract] [Full Text] [Related]
6. Dominant effects of Δ40p53 on p53 function and melanoma cell fate.
Takahashi R; Markovic SN; Scrable HJ
J Invest Dermatol; 2014 Mar; 134(3):791-800. PubMed ID: 24037342
[TBL] [Abstract][Full Text] [Related]
7. Δ40p53 isoform up-regulates netrin-1/UNC5B expression and potentiates netrin-1 pro-oncogenic activity.
Sun Y; Manceau A; Frydman L; Cappuccio L; Neves D; Basso V; Wang H; Fombonne J; Maisse C; Mehlen P; Paradisi A
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34470826
[TBL] [Abstract][Full Text] [Related]
8. The "LINC" between Δ40p53-miRNA Axis in the Regulation of Cellular Homeostasis.
Pal A; Ghosh PK; Das S
Mol Cell Biol; 2023; 43(7):335-353. PubMed ID: 37283188
[TBL] [Abstract][Full Text] [Related]
9. Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.
Avery-Kiejda KA; Zhang XD; Adams LJ; Scott RJ; Vojtesek B; Lane DP; Hersey P
Clin Cancer Res; 2008 Mar; 14(6):1659-68. PubMed ID: 18310316
[TBL] [Abstract][Full Text] [Related]
10. WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells.
Cuddihy AR; Jalali F; Coackley C; Bristow RG
Mol Cancer Ther; 2008 Apr; 7(4):980-92. PubMed ID: 18413811
[TBL] [Abstract][Full Text] [Related]
11. p53 isoform expression promotes a stemness phenotype and inhibits doxorubicin sensitivity in breast cancer.
Steffens Reinhardt L; Groen K; Zhang X; Morten BC; Wawruszak A; Avery-Kiejda KA
Cell Death Dis; 2023 Aug; 14(8):509. PubMed ID: 37553320
[TBL] [Abstract][Full Text] [Related]
12. Loss of the p53 transactivation domain results in high amyloid aggregation of the Δ40p53 isoform in endometrial carcinoma cells.
Melo Dos Santos N; de Oliveira GAP; Ramos Rocha M; Pedrote MM; Diniz da Silva Ferretti G; Pereira Rangel L; Morgado-Diaz JA; Silva JL; Rodrigues Pereira Gimba E
J Biol Chem; 2019 Jun; 294(24):9430-9439. PubMed ID: 31028175
[TBL] [Abstract][Full Text] [Related]
13. The Δ133p53 Isoform Reduces Wtp53-induced Stimulation of DNA Pol γ Activity in the Presence and Absence of D4T.
Liu K; Zang Y; Guo X; Wei F; Yin J; Pang L; Chen D
Aging Dis; 2017 Apr; 8(2):228-239. PubMed ID: 28400988
[TBL] [Abstract][Full Text] [Related]
14. Delta40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs.
Ungewitter E; Scrable H
Genes Dev; 2010 Nov; 24(21):2408-19. PubMed ID: 21041409
[TBL] [Abstract][Full Text] [Related]
15. Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53.
Supiot S; Hill RP; Bristow RG
Mol Cancer Ther; 2008 Apr; 7(4):993-9. PubMed ID: 18413812
[TBL] [Abstract][Full Text] [Related]
16. Post-translational regulation of p53 function through 20S proteasome-mediated cleavage.
Solomon H; Bräuning B; Fainer I; Ben-Nissan G; Rabani S; Goldfinger N; Moscovitz O; Shakked Z; Rotter V; Sharon M
Cell Death Differ; 2017 Dec; 24(12):2187-2198. PubMed ID: 28885617
[TBL] [Abstract][Full Text] [Related]
17. The N-terminally truncated p53 isoform Δ40p53 influences prognosis in mucinous ovarian cancer.
Hofstetter G; Berger A; Berger R; Zorić A; Braicu EI; Reimer D; Fiegl H; Marth C; Zeimet AG; Ulmer H; Moll U; Zeillinger R; Concin N
Int J Gynecol Cancer; 2012 Mar; 22(3):372-9. PubMed ID: 22246403
[TBL] [Abstract][Full Text] [Related]
18. Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities.
Iyer SV; Parrales A; Begani P; Narkar A; Adhikari AS; Martinez LA; Iwakuma T
Oncotarget; 2016 Feb; 7(5):5401-15. PubMed ID: 26700961
[TBL] [Abstract][Full Text] [Related]
19. Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells.
Liang Y; Besch-Williford C; Benakanakere I; Hyder SM
Int J Oncol; 2007 Oct; 31(4):777-84. PubMed ID: 17786308
[TBL] [Abstract][Full Text] [Related]
20. Hdm2 and nitric oxide radicals contribute to the p53-dependent radioadaptive response.
Takahashi A; Matsumoto H; Ohnishi T
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):550-8. PubMed ID: 18410999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
